Released Aug 13, 2010, during market hours
10-Q filed Aug 13, 2010, 44 days after period end · 0001019687-10-003003
Q2 2010 · 10-Q
Revenue$6.19M$6.19M no prior Q2 2009 on file
Net Income-$457.00K-$457.00K no prior Q2 2009 on file
EPS Diluted-$0.01-$0.01 no prior Q2 2009 on file
Operating Income-$407,000—
Margins · derived
Operating margin-6.6%
Net margin-7.4%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q2 2009 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ernexa Therapeutics Inc. · CIK 748592 · Engraved from SEC EDGAR